A study to investigate the pharmacokinetics of AZD0780 when administered alone and in combination with itraconazole and carbamazepine in healthy participants aged 18 to 75 years of age - Not Applicable

Study identifier:D7960C00011

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

An open-label, fixed sequence study in healthy participants to assess the pharmacokinetics of AZD0780 when administered alone and in combination with itraconazole and carbamazepine

Medical condition

dyslipidaemia

Phase

Phase 2

Healthy volunteers

Yes

Study drug

AZD0780

Sex

All

Estimated Enrollment

42

Study type

Interventional

Age

18 Years - 75 Years

Date

Study Start Date: 24 Sept 2024
Estimated Primary Completion Date: 06 Jun 2025
Estimated Study Completion Date: 06 Jun 2025

Study design

Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: Sequential Assignment
Masking: -
Primary Purpose: Other

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria